Candriam Equities L Oncology Impact, N - Capitalisation/ LU2346866317 /
| NAV6/7/2024 | Chg.+0.7500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 158.3700EUR | +0.48% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | - | - | 1.59 | -2.53 | 0.81 | 2.76 | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | -% | -% | -% | -% | -% |
| Sharpe ratio | - | - | - | - | - |
| Best month | +2.76% | +2.76% | +2.76% | - | - |
| Worst month | -2.53% | -2.53% | -2.53% | - | - |
| Maximum loss | - | - | - | - | - |
| Outperformance | - | - | - | - | - |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,399.0500 | +8.63% | +4.84% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,563.7100 | +8.77% | +5.23% | |
| Candriam Equities L Oncology Imp... | reinvestment | 207.4400 | +5.05% | -6.00% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,240.9199 | +6.07% | +15.66% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,609.7500 | +8.28% | +3.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 246.3900 | +6.23% | +13.78% | |
| Candriam Equities L Oncology Imp... | paying dividend | 235.9300 | +7.27% | +0.96% | |
| Candriam Equities L Oncology Imp... | paying dividend | 191.1300 | +8.19% | +3.53% | |
| Candriam Equities L Oncology Imp... | paying dividend | 20,700.0000 | +3.50% | +0.87% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.5300 | +5.95% | +15.27% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,110.1499 | +6.05% | -3.31% | |
| Candriam Equities L Oncology Imp... | reinvestment | 261.1800 | +7.13% | +16.69% | |
| Candriam Equities L Oncology Imp... | reinvestment | 206.8800 | +4.63% | -7.11% | |
| Candriam Equities L Oncology Imp... | reinvestment | 286.5900 | +8.17% | +3.52% | |
| Candriam Equities L Oncology Imp... | reinvestment | 193.8000 | +5.93% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,848.6700 | +6.41% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,881.3601 | +8.28% | +3.83% | |
| Candriam Equities L Oncology Imp... | reinvestment | 158.3700 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 274.1100 | +7.27% | +0.94% |
Performance
| YTD | - | ||
|---|---|---|---|
| 6 Months | - | ||
| 1 Year | - | ||
| 3 Years | - | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +3.82% | ||
| Year | |||
